Annual EBITDA
$98.12 M
+$210.72 M+187.14%
December 31, 2021
Summary
- As of February 10, 2025, IDRA annual EBITDA is $98.12 million, with the most recent change of +$210.72 million (+187.14%) on December 31, 2021.
- During the last 3 years, IDRA annual EBITDA has risen by +$157.56 million (+265.08%).
Performance
IDRA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$9.13 M
-$3.83 M-72.26%
September 30, 2022
Summary
- As of February 10, 2025, IDRA quarterly EBITDA is -$9.13 million, with the most recent change of -$3.83 million (-72.26%) on September 30, 2022.
- Over the past year, IDRA quarterly EBITDA has dropped by -$3.18 million (-53.30%).
Performance
IDRA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$22.73 M
-$3.18 M-16.25%
September 30, 2022
Summary
- As of February 10, 2025, IDRA TTM EBITDA is -$22.73 million, with the most recent change of -$3.18 million (-16.25%) on September 30, 2022.
- Over the past year, IDRA TTM EBITDA has dropped by -$48.27 million (-188.96%).
Performance
IDRA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IDRA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +187.1% | -53.3% | -189.0% |
| 3 y3 years | +265.1% | +19.6% | +59.7% |
| 5 y5 years | +250.5% | +36.2% | +59.7% |
IDRA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +122.0% | at low | -123.2% | at low |
| 5 y | 5-year | at high | -214.8% | -107.9% | +739.5% | -123.2% | +395.5% |
| alltime | all time | at high | -214.8% | -107.9% | +739.5% | -123.2% | +395.5% |
Idera Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$9.13 M(+72.3%) | -$22.73 M(+16.2%) |
| Jun 2022 | - | -$5.30 M(+27.0%) | -$19.55 M(-10.3%) |
| Mar 2022 | - | -$4.17 M(+1.5%) | -$21.80 M(-122.2%) |
| Dec 2021 | $98.12 M(-187.1%) | -$4.11 M(-31.0%) | $98.12 M(+284.1%) |
| Sep 2021 | - | -$5.96 M(-21.1%) | $25.55 M(+133.0%) |
| Jun 2021 | - | -$7.55 M(-106.5%) | $10.96 M(-292.6%) |
| Mar 2021 | - | $115.75 M(-250.9%) | -$5.69 M(-94.9%) |
| Dec 2020 | -$112.60 M(+99.7%) | -$76.69 M(+273.3%) | -$112.60 M(+93.1%) |
| Sep 2020 | - | -$20.54 M(-15.2%) | -$58.30 M(+18.7%) |
| Jun 2020 | - | -$24.21 M(-373.8%) | -$49.11 M(+35.1%) |
| Mar 2020 | - | $8.84 M(-139.5%) | -$36.34 M(-35.6%) |
| Dec 2019 | -$56.40 M(-5.1%) | -$22.39 M(+97.2%) | -$56.40 M(+22.3%) |
| Sep 2019 | - | -$11.36 M(-0.7%) | -$46.12 M(-0.4%) |
| Jun 2019 | - | -$11.44 M(+2.0%) | -$46.29 M(-8.7%) |
| Mar 2019 | - | -$11.21 M(-7.5%) | -$50.73 M(-14.7%) |
| Dec 2018 | -$59.44 M(-8.8%) | -$12.11 M(+5.0%) | -$59.44 M(-4.2%) |
| Sep 2018 | - | -$11.53 M(-27.4%) | -$62.05 M(-4.3%) |
| Jun 2018 | - | -$15.88 M(-20.3%) | -$64.85 M(-7.7%) |
| Mar 2018 | - | -$19.92 M(+35.2%) | -$70.24 M(+7.8%) |
| Dec 2017 | -$65.19 M(+73.1%) | -$14.73 M(+2.8%) | -$65.19 M(+31.8%) |
| Sep 2017 | - | -$14.33 M(-32.6%) | -$49.45 M(+3.4%) |
| Jun 2017 | - | -$21.27 M(+43.1%) | -$47.84 M(+20.0%) |
| Mar 2017 | - | -$14.87 M(-1570.3%) | -$39.88 M(+5.9%) |
| Dec 2016 | -$37.65 M(-21.5%) | $1.01 M(-107.9%) | -$37.65 M(-25.4%) |
| Sep 2016 | - | -$12.72 M(-4.4%) | -$50.49 M(+3.1%) |
| Jun 2016 | - | -$13.30 M(+5.2%) | -$48.98 M(+1.5%) |
| Mar 2016 | - | -$12.64 M(+6.9%) | -$48.25 M(+0.6%) |
| Dec 2015 | -$47.96 M(+24.9%) | -$11.82 M(+5.5%) | -$47.96 M(+0.0%) |
| Sep 2015 | - | -$11.21 M(-10.9%) | -$47.96 M(+3.9%) |
| Jun 2015 | - | -$12.58 M(+1.8%) | -$46.15 M(+10.3%) |
| Mar 2015 | - | -$12.35 M(+4.5%) | -$41.85 M(+8.9%) |
| Dec 2014 | -$38.41 M(+113.0%) | -$11.82 M(+25.8%) | -$38.44 M(+17.7%) |
| Sep 2014 | - | -$9.40 M(+13.5%) | -$32.66 M(+17.0%) |
| Jun 2014 | - | -$8.28 M(-7.4%) | -$27.92 M(+20.5%) |
| Mar 2014 | - | -$8.94 M(+48.0%) | -$23.17 M(+28.5%) |
| Dec 2013 | -$18.03 M(-8.2%) | -$6.04 M(+29.9%) | -$18.03 M(+10.8%) |
| Sep 2013 | - | -$4.65 M(+31.6%) | -$16.27 M(-0.3%) |
| Jun 2013 | - | -$3.53 M(-7.1%) | -$16.32 M(-9.5%) |
| Mar 2013 | - | -$3.81 M(-11.1%) | -$18.05 M(-8.2%) |
| Dec 2012 | -$19.65 M(-22.5%) | -$4.28 M(-8.9%) | -$19.65 M(-12.6%) |
| Sep 2012 | - | -$4.70 M(-10.6%) | -$22.48 M(-3.0%) |
| Jun 2012 | - | -$5.26 M(-2.8%) | -$23.18 M(-3.7%) |
| Mar 2012 | - | -$5.41 M(-23.9%) | -$24.07 M(-5.1%) |
| Dec 2011 | -$25.36 M(+45.6%) | -$7.11 M(+31.7%) | -$25.36 M(+5.3%) |
| Sep 2011 | - | -$5.40 M(-12.2%) | -$24.09 M(+2.7%) |
| Jun 2011 | - | -$6.15 M(-8.3%) | -$23.45 M(+4.1%) |
| Mar 2011 | - | -$6.70 M(+14.7%) | -$22.52 M(+29.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$17.41 M(-315.9%) | -$5.84 M(+22.7%) | -$17.41 M(+129.3%) |
| Sep 2010 | - | -$4.76 M(-8.7%) | -$7.59 M(+186.0%) |
| Jun 2010 | - | -$5.22 M(+226.6%) | -$2.65 M(-139.9%) |
| Mar 2010 | - | -$1.60 M(-140.1%) | $6.65 M(-17.5%) |
| Dec 2009 | $8.07 M(+276.5%) | $3.98 M(+2122.9%) | $8.07 M(+47.5%) |
| Sep 2009 | - | $179.00 K(-95.6%) | $5.47 M(-22.4%) |
| Jun 2009 | - | $4.09 M(-2336.1%) | $7.05 M(+75.7%) |
| Mar 2009 | - | -$183.00 K(-113.2%) | $4.01 M(+87.1%) |
| Dec 2008 | $2.14 M(-114.9%) | $1.38 M(-21.3%) | $2.14 M(-154.1%) |
| Sep 2008 | - | $1.76 M(+66.4%) | -$3.96 M(-56.7%) |
| Jun 2008 | - | $1.05 M(-151.5%) | -$9.15 M(-32.6%) |
| Mar 2008 | - | -$2.05 M(-56.6%) | -$13.57 M(-5.6%) |
| Dec 2007 | -$14.38 M(-10.8%) | -$4.72 M(+37.6%) | -$14.38 M(+0.9%) |
| Sep 2007 | - | -$3.43 M(+1.9%) | -$14.25 M(-2.2%) |
| Jun 2007 | - | -$3.37 M(+17.9%) | -$14.56 M(-5.8%) |
| Mar 2007 | - | -$2.86 M(-37.7%) | -$15.46 M(-4.0%) |
| Dec 2006 | -$16.11 M(+19.4%) | -$4.59 M(+22.5%) | -$16.11 M(+5.3%) |
| Sep 2006 | - | -$3.75 M(-12.2%) | -$15.29 M(+6.3%) |
| Jun 2006 | - | -$4.27 M(+21.7%) | -$14.39 M(+4.5%) |
| Mar 2006 | - | -$3.51 M(-7.0%) | -$13.76 M(+2.0%) |
| Dec 2005 | -$13.50 M(+7.0%) | -$3.77 M(+32.9%) | -$13.50 M(+7.5%) |
| Sep 2005 | - | -$2.84 M(-22.1%) | -$12.55 M(-8.3%) |
| Jun 2005 | - | -$3.64 M(+12.4%) | -$13.69 M(+3.8%) |
| Mar 2005 | - | -$3.24 M(+14.6%) | -$13.19 M(+4.5%) |
| Dec 2004 | -$12.62 M(-26.2%) | -$2.83 M(-28.7%) | -$12.62 M(-11.4%) |
| Sep 2004 | - | -$3.97 M(+26.4%) | -$14.24 M(+2.6%) |
| Jun 2004 | - | -$3.14 M(+17.4%) | -$13.88 M(-6.4%) |
| Mar 2004 | - | -$2.68 M(-39.9%) | -$14.83 M(-14.4%) |
| Dec 2003 | -$17.10 M(-203.1%) | -$4.45 M(+23.3%) | -$17.32 M(+4.6%) |
| Sep 2003 | - | -$3.61 M(-11.7%) | -$16.56 M(-268.4%) |
| Jun 2003 | - | -$4.09 M(-21.0%) | $9.84 M(-21.5%) |
| Mar 2003 | - | -$5.17 M(+40.2%) | $12.53 M(-24.5%) |
| Dec 2002 | $16.58 M(+53.5%) | -$3.69 M(-116.2%) | $16.58 M(-57.2%) |
| Sep 2002 | - | $22.79 M(-1728.2%) | $38.74 M(+171.6%) |
| Jun 2002 | - | -$1.40 M(+25.6%) | $14.26 M(+15.3%) |
| Mar 2002 | - | -$1.11 M(-106.0%) | $12.38 M(+10.9%) |
| Dec 2001 | $10.80 M(-287.8%) | $18.47 M(-1193.3%) | $11.16 M(-228.2%) |
| Sep 2001 | - | -$1.69 M(-48.6%) | -$8.71 M(+6.6%) |
| Jun 2001 | - | -$3.29 M(+41.4%) | -$8.17 M(+19.8%) |
| Mar 2001 | - | -$2.33 M(+66.0%) | -$6.82 M(+19.4%) |
| Dec 2000 | -$5.75 M(-3.8%) | -$1.40 M(+21.4%) | -$5.71 M(+32.5%) |
| Sep 2000 | - | -$1.15 M(-40.4%) | -$4.31 M(+36.5%) |
| Jun 2000 | - | -$1.94 M(+58.7%) | -$3.16 M(+158.7%) |
| Mar 2000 | - | -$1.22 M | -$1.22 M |
| Dec 1999 | -$5.98 M(-68.5%) | - | - |
| Dec 1998 | -$18.99 M(-61.6%) | - | - |
| Dec 1997 | -$49.42 M(+11.5%) | - | - |
| Dec 1996 | -$44.33 M | - | - |
FAQ
- What is Idera Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals annual EBITDA year-on-year change?
- What is Idera Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Idera Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals TTM EBITDA year-on-year change?
What is Idera Pharmaceuticals annual EBITDA?
The current annual EBITDA of IDRA is $98.12 M
What is the all time high annual EBITDA for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual EBITDA is $98.12 M
What is Idera Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, IDRA annual EBITDA has changed by +$210.72 M (+187.14%)
What is Idera Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of IDRA is -$9.13 M
What is the all time high quarterly EBITDA for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly EBITDA is $115.75 M
What is Idera Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, IDRA quarterly EBITDA has changed by -$3.18 M (-53.30%)
What is Idera Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of IDRA is -$22.73 M
What is the all time high TTM EBITDA for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high TTM EBITDA is $98.12 M
What is Idera Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, IDRA TTM EBITDA has changed by -$48.27 M (-188.96%)